Chapter 25: Thoracic Flashcards
Runs along the right side and dumps into the SVC
Azygous vein
Runs along the right side, crosses midline at T4-T5, and dumps into left subclavian vein at junction with internal jugular vein
Thoracic duct
Nerve runs anterior to hilum
Phrenic nerve
Nerve runs posterior to hilum
Vagus nerve
Right lung volume
55% (3 lobes: RUL, RML, RLL)
Left lung volume
45% (2 lobes: LUL and LLL and lingula)
Muscles involved in quite inspiration
Diaphragm 80%
Intercostals 20%
Greatest change in dimension when breathing
Anterior and posterior
Accessory muscles of inspiration
SCM, levators, serratus posterior, scalenes
Function: type 1 pneumocytes
Gas exchange
Function: type 2 pneumocytes
Surfactant production
Function: pores of Kahn
direct air exchange between alveoli
Predicted postop requirements:
FEV1
DLCO
- FEV1 > 0.8 (or >40% of the predicted post value)
- DLCO > 10mL/min/mmHg CO (or > 40% of the predicted post value)
What if predicted postop FEV1 is not > 0.8 but is close?
If it is close -> get qualitative V/Q scan to see contribution of that portion of the lung to overall FEV1 -> if low, may still be able to resect
- Measures carbon monoxide diffusion and represents oxygen exchange capacity
- This value depends on pulmonary capillary surface area, hemoglobin content, and alveolar architecture.
DLCO
pre op pCO2, pO2, VO2 max that say no resection
pCO2 > 50 at rest
pO2
MC after segmentectomy / wedge
Persistent air leak
MC after lobectomy
Atelectasis
MC after pneumonectomy
Arrhythmias
Symptoms: can be asymptomatic with finding on routine CXR; cough, hemoptysis, atelectasis, PNA, pain, weight loss
Lung cancer
MCC cancer-related death in the United States
Lung cancer
Strongest influence on survival in lung cancer
Nodal involvement
Lung cancer: single most common site of metastasis
Brain
- Can also go to supraclavicular nodes, other lung, bone, liver, and adrenals
Usually appears as disseminated metastasis
Recurrence
- 80% of recurrences are within the 1st three years
Overall 5-year survival rate lung cancer
10% 5-year survival rate
- 30% with resection for cure
What lung cancer is resectable?
Stage 1 and 2 disease resectable; T3,N1,M0 (stage3a) possibly resectable
MC procedure for lung cancer
Lobectomy or pneumonectomy; sample suspicious nodes
80% of lung cancer
Non-small cell carcinoma
Lung cancer: usually more central
Squamous cell carcinoma
Lung cancer: usually more peripheral
Adenocarcinoma
MC lung cancer
Adenocarcinoma (not squamous)
TNM staging system for lung cancer
T: 1 (3cm but >2cm away from carina) 3(invasion of chest wall, pericardium, diaphragm or
- 20% of lung cancer; neuroendocrine in origin
- usually unresectable at time of diagnosis (
Small cell carcinoma
Overall 5 year survival rate of small cell carcinoma
Small cell carcinoma: 5 year survival rate T1, N0, M0
50%
Most treatment for small cell carcinoma
Just get chemo-XRT
Paraneoplastic syndrome: squamous cell CA
PTH-related peptide
Paraneoplastic syndrome: small cell CA
ACTH and ADH
Most common paraneoplastic syndrome
Small cell ACTH
- Most malignant lung tumor
- Aggressive local invasion, nodal invasion, and distant metastases common at the time of diagnosis.
Mesothelioma
What is mesothelioma related to?
Asbestos exposure
Non-small cell CA chemotherapy (stage 2 or higher)
Carboplatin, Taxol
Small cell lung CA chemotherapy
Cisplatin, etoposide
Can XRT be used for lung CA?
Yes
Single best test for clinical assessment of T and N status for lung cancer
Chest and abdominal CT scan
Best test for M status in lung cancer?
PET scan
Use for centrally located tumors and patients with suspicious adenopathy (> 0.8 cm or subcarinal > 1.0 cm) on chest CT
Mediastinoscopy
What does mediastinoscopy assess?
- Does not assess aorto-pulmonary (AP) window nodes (left lung drainage)
- Assesses ipsilateral (N2) and contralateral (N3) mediastinal nodes
Treatment if mediastinal nodes are positive
Tumor is unresectable
Looking into middle mediastinum with mediastinoscopy:
- Left-side structures
- Right side structures
- Anterior
Left-side: RLN, esophagus, aorta, main pulmonary artery (PA)
Right-side: azygous and SVC
Anterior: innominate vein, innominate artery, right PA
assesses enlarged AP window nodes; go thru left 2nd rib cage
Chamberlain procedure (anterior thoracotomy or parasternal mediastinotomy)
Needed for centrally located tumors to check for airway invasion
Bronchoscopy
For lung CA, patients need to be…
1) operable (FEV1/DLCO)
2) resectable (can’t have T4, N2, N3, or M disease)
Tumor invades apex of chest wall and patients have Horner’s syndrome (invasion of sympathetic chain - ptosis miosis, anhidrosis) or ulnar nerve symptoms
Pancoast tumor
- Overall, 10% are malignant.
- Age 50 -> >50% malignant
- No growth in 2 years, and smooth contour suggests benign disease
coin lesion
Management of suspicious coin lesion
if suspicious, will need either guided biopsy or wedge resection
Increased lung CA risk 90x
Asbestos exposure
Can look like pneumonia; grows along alveolar walls; multifocal
Bronchoalveolar cancer
Management: metastases to the lung -> if isolated and not associated with any other systemic disease
May be resected for colon, renal cell CA, sarcoma, melanoma, ovarian, and endometrial CA
Neuroendocrine tumor, usually central
- 5% have metastases at time of diagnosis; 50% have symptoms (cough, hemoptysis)
Carcinoids
5-year Survival rate: typical carcinoid
90%
5-year Survival rate: atypical carcinoid
60%
Tx: carcinoid
Resection, treat like cancer, outcome closely linked to histology
Malignant bronchial adenomas
Mucoepidermoid adenoma, mucous gland adenoma, and adenoid cystic adenoma
Type - bronchial adenomas
- Slow growth, no metastases
- Tx: resection
Mucoepidermoid adenoma, and mucous gland adenoma
- From submucosal glands; spreads along perineural lymphatics, well beyond endoluminal component; very XRT sensitive
- Slow growing; can get 10-year survival with incomplete resection
- Tx: resection; if unresectable, XRT can provide good palliation
Adenoid cystic adenoma